A Vandenbroucke, F P Luyten, J Flamaing, E Gielen
The incidence of osteoporotic fractures increases with age. Consequently, the global prevalence of osteoporotic fractures will increase with the aging of the population. In old age, osteoporosis is associated with a substantial burden in terms of morbidity and mortality. Nevertheless, osteoporosis in old age continues to be underdiagnosed and undertreated. This may, at least partly, be explained by the fact that evidence of the antifracture efficacy of osteoporosis treatments comes mainly from randomized controlled trials in postmenopausal women with a mean age of 70-75 years...
2017: Clinical Interventions in Aging
M Moallem, H Parsian, A Mosapour, S R Hosseini, H Nooreddini, Z Shirhanik, M Pouramir
OBJECTIVE: The occurrence of osteopenia and osteoporosis is a major problem of ageing. For assessing the severity of bone loss, bone mineral density (BMD) measurement is the gold standard. Because of the limitations of BMD, use of simpler serum-based tests to classify osteoporosis/osteopenia patients is gaining interest. In this preliminary work, we aimed to discriminate between healthy individuals and osteoporosis/osteopenia patients through a simple serum-based equation. METHODS: In this study, blood from 84 elderly persons were collected and levels of vitamin D, calcium (Ca), phosphorus (P), copper (Cu) and strontium (Sr) were analysed...
May 6, 2015: West Indian Medical Journal
Lin Zhou, Qian Liu, Mingli Yang, Tao Wang, Jun Yao, Jianwen Cheng, Jinbo Yuan, Xixi Lin, Jinmin Zhao, Jennifer Tickner, Jiake Xu
Osteoporosis is an osteolytic disease that features enhanced osteoclast formation and bone resorption. Identification of agents that can inhibit osteoclast formation and function is important for the treatment of osteoporosis. Dihydroartemisinin is a natural compound used to treat malaria but its role in osteoporosis is not known. Here, we found that dihydroartemisinin can suppress RANKL-induced osteoclastogenesis and bone resorption in a dose-dependent manner. Dihydroartemisinin inhibited the expression of osteoclast marker genes such as cathepsin K, calcitonin receptor, and tartrate-resistant acid phosphatase (TRAcP)...
May 2016: Journal of Bone and Mineral Research
Robert A Adler, Ghada El-Hajj Fuleihan, Douglas C Bauer, Pauline M Camacho, Bart L Clarke, Gregory A Clines, Juliet E Compston, Matthew T Drake, Beatrice J Edwards, Murray J Favus, Susan L Greenspan, Ross McKinney, Robert J Pignolo, Deborah E Sellmeyer
Bisphosphonates (BPs) are the most commonly used medications for osteoporosis. This ASBMR report provides guidance on BP therapy duration with a risk-benefit perspective. Two trials provided evidence for long-term BP use. In the Fracture Intervention Trial Long-term Extension (FLEX), postmenopausal women receiving alendronate for 10 years had fewer clinical vertebral fractures than those switched to placebo after 5 years. In the HORIZON extension, women who received 6 annual infusions of zoledronic acid had fewer morphometric vertebral fractures compared with those switched to placebo after 3 years...
January 2016: Journal of Bone and Mineral Research
Adi Cohen, Mafo Kamanda-Kosseh, Robert R Recker, Joan M Lappe, David W Dempster, Hua Zhou, Serge Cremers, Mariana Bucovsky, Julie Stubby, Elizabeth Shane
CONTEXT: Without antiresorptive therapy, postmenopausal women lose bone mass after teriparatide (TPTD) discontinuation; estrogen treatment prevents bone loss in this setting. It is not known whether premenopausal women with regular menses lose bone mass after teriparatide discontinuation. OBJECTIVE: This study aimed to test the hypothesis that normally menstruating premenopausal women with idiopathic osteoporosis (IOP) will maintain teriparatide-associated bone mineral density (BMD) gains after medication cessation...
November 2015: Journal of Clinical Endocrinology and Metabolism
Garry R Brock, Julia T Chen, Anthony R Ingraffea, Jennifer MacLeay, G Elizabeth Pluhar, Adele L Boskey, Marjolein C H van der Meulen
Bisphosphonates are commonly prescribed for treatment of osteoporosis. Long-term use of bisphosphonates has been correlated to atypical femoral fractures (AFF). AFFs arise from fatigue damage to bone tissue that cannot be repaired due to pharmacologic treatments. Despite fatigue being the primary damage mechanism of AFFs, the effects of osteoporosis treatments on fatigue properties of cortical bone are unknown. To examine if fatigue-life differences occur in bone tissue after different pharmacologic treatments for osteoporosis, we tested bone tissue from the femurs of sheep given a metabolic acidosis diet to induce osteoporosis, followed by treatment with a selective estrogen reception modulator (raloxifene), a bisphosphonate (alendronate or zoledronate), or parathyroid hormone (teriparatide, PTH)...
June 1, 2015: Bone Reports
S Nayak, D L Edwards, A A Saleh, S L Greenspan
UNLABELLED: We performed a systematic review and meta-analysis of the performance of clinical risk assessment instruments for screening for DXA-determined osteoporosis or low bone density. Commonly evaluated risk instruments showed high sensitivity approaching or exceeding 90% at particular thresholds within various populations but low specificity at thresholds required for high sensitivity. Simpler instruments, such as OST, generally performed as well as or better than more complex instruments...
May 2015: Osteoporosis International
Virginie Vives, Gaëlle Cres, Christian Richard, Muriel Busson, Yann Ferrandez, Anne-Gaelle Planson, Mahel Zeghouf, Jacqueline Cherfils, Luc Malaval, Anne Blangy
Osteoporosis is caused by excessive activity of bone-degrading osteoclasts over bone-forming osteoblast. Standard antiosteolytic treatments inhibit bone resorption by inducing osteoclast loss, with the adverse effect of hindering also bone formation. Formation of the osteoclast sealing zone requires Dock5, a guanine nucleotide exchange factor for the small GTPase Rac, and C21, a chemical inhibitor of Dock5, decreases bone resorption by cultured osteoclasts. Here we show that C21 directly inhibits the exchange activity of Dock5 and disrupts osteoclast podosome organization...
February 3, 2015: Nature Communications
Cristiana Cipriani, Federica Biamonte, Aline G Costa, Chiyuan Zhang, Piergianni Biondi, Daniele Diacinti, Jessica Pepe, Sara Piemonte, Alfredo Scillitani, Salvatore Minisola, John P Bilezikian
CONTEXT: The fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism (PHPT) has recently suggested that skeletal and renal imaging be routinely conducted. So far, no study has systematically assessed this issue. OBJECTIVE: The objective was to evaluate the prevalence of kidney stones (KS) and vertebral fractures (VFs) in a cohort of patients with PHPT utilizing noninvasive imaging technology. DESIGN: This was a prospective study evaluating patients consecutively diagnosed with PHPT in a single center over a 5-year period (2009-2013)...
April 2015: Journal of Clinical Endocrinology and Metabolism
Maurizio Rossini, Giovanni Orsolini, Ombretta Viapiana, Silvano Adami, Davide Gatti
In glucocorticoid-induced osteoporosis (GIO), both bone formation and resorption are altered, however, with a relative prevalence of resorption, consistent with the positive results that have been reported with bisphosphonate treatment. Many studies have investigated the effect of bisphosphonates (BPs), a widely used class of anti-resorptive drugs, showing a positive effect on bone mineral density and fracture risk. Also in case of postmenopausal osteoporosis, the safety and cost-effectiveness profile of BPs in GIO appears good...
August 2015: Endocrine
Junichiro James Kazama, Koji Matsuo, Yoshiko Iwasaki, Masafumi Fukagawa
Chronic kidney disease-related mineral and bone disease (CKD-MBD) is a syndrome defined as a systemic mineral metabolic disorder associated with CKD, and the term renal osteodystrophy indicates a pathomorphological concept of bone lesions associated with CKD-MBD. Cortical bone thinning, abnormalities in bone turnover and primary/secondary mineralization, elevated levels of circulating sclerostin, increased apoptosis in osteoblasts and osteocytes, disturbance of the coupling phenomenon, iatrogenic factors, accumulated micro-crackles, crystal/collagen disorientation, and chemical modification of collagen crosslinks are all possible candidates found in CKD that could promote osteopenia and/or bone fragility...
May 2015: Journal of Bone and Mineral Metabolism
Klaus Engelke, Thomas Fuerst, Bernard Dardzinski, John Kornak, Shabana Ather, Harry K Genant, Anne de Papp
Odanacatib, a selective cathepsin K inhibitor, increases areal bone mineral density (aBMD) at the spine and hip of postmenopausal women. To gain additional insight into the effects on trabecular and cortical bone, we analyzed quantitative computed tomography (QCT) data of postmenopausal women treated with odanacatib using Medical Image Analysis Framework (MIAF; Institute of Medical Physics, University of Erlangen, Erlangen, Germany). This international, randomized, double-blind, placebo-controlled, 2-year, phase 3 trial enrolled 214 postmenopausal women (mean age 64 years) with low aBMD...
January 2015: Journal of Bone and Mineral Research
Elizabeth N Martin, Elizabeth M Haney, Jackie Shannon, Jane A Cauley, Kristine E Ensrud, Tony M Keaveny, Joseph M Zmuda, Eric S Orwoll, Stephanie Litwack Harrison, Lynn M Marshall
Low serum 25-hydroxy vitamin D (25(OH)D) concentrations are associated with increased hip fracture risk and decreased femoral areal bone mineral density (BMD) among elderly men. Structural dimensions of the proximal femur and volumetric BMD in cortical and trabecular compartments are also associated with hip fracture risk. However, associations of volumetric BMD or structural dimensions with serum 25(OH)D concentrations among older men remain unclear. In a random sample of 1608 men aged ≥65 years from the Osteoporotic Fractures in Men Study (MrOS), baseline serum 25(OH)D concentrations were measured by liquid chromatography/mass spectrometry assays...
March 2015: Journal of Bone and Mineral Research
Jung Hee Kim, Hyung Jin Choi, Eu Jeong Ku, Kyoung Min Kim, Sang Wan Kim, Nam H Cho, Chan Soo Shin
CONTEXT: Trabecular bone score (TBS) is a novel texture index that evaluates the pixel gray-level variations in lumbar spine dual-energy X-ray absorptiometry images and is related to bone microarchitecture independent of bone mineral density (BMD). OBJECTIVE: We investigated lumbar spine TBS as an indicator for skeletal deterioration in diabetes. DESIGN AND SETTING: Cross-sectional data were collected from subjects participating in an ongoing prospective, community-based, cohort study from 2009 to 2010...
February 2015: Journal of Clinical Endocrinology and Metabolism
Christian Meier, Tuan V Nguyen, Jacqueline R Center, Markus J Seibel, John A Eisman
UNLABELLED: Among the potential risk factors for fragility fractures, bone turnover is considered an important determinant. In a case-cohort control study of 151 elderly men followed prospectively over 6.3 years, high bone resorption as assessed by S-ICTP was associated with increased risk of osteoporotic fracture, independent of BMD. Combining measurements of BMD and bone turnover may improve fracture prediction in elderly men. INTRODUCTION: Approximately one-third of osteoporotic fractures occur in men...
April 2005: Journal of Bone and Mineral Research
Lisa Langsetmo, Tuan V Nguyen, Nguyen D Nguyen, Christopher S Kovacs, Jerilynn C Prior, Jacqueline R Center, Suzanne Morin, Robert G Josse, Jonathan D Adachi, David A Hanley, John A Eisman
BACKGROUND: A set of nomograms based on the Dubbo Osteoporosis Epidemiology Study predicts the five- and ten-year absolute risk of fracture using age, bone mineral density and history of falls and low-trauma fracture. We assessed the discrimination and calibration of these nomograms among participants in the Canadian Multicentre Osteoporosis Study. METHODS: We included participants aged 55-95 years for whom bone mineral density measurement data and at least one year of follow-up data were available...
February 8, 2011: Canadian Medical Association Journal: CMAJ
S Yang, N D Nguyen, J R Center, J A Eisman, T V Nguyen
UNLABELLED: Hypertension is an independent risk factor for osteoporosis and osteoporotic fracture in postmenopausal women. INTRODUCTION: Although hypertension has been suggested to be associated with increased fracture risk, it is not clear whether the association is independent of bone mineral density (BMD). The present study sought to examine the interrelationships between hypertension, BMD, and fracture risk. METHODS: The study included 1,032 men and 1,701 women aged 50 years and older who were participants in the Dubbo Osteoporosis Epidemiology Study...
January 2014: Osteoporosis International
Dana Bliuc, Dunia Alarkawi, Tuan V Nguyen, John A Eisman, Jacqueline R Center
Half of fragility fractures occur in individuals with nonosteoporotic BMD (BMD T-score > -2.5); however, there is no information on postfracture adverse events of subsequent fracture and mortality for different BMD levels. The objective of this work was to determine the risk and predictors of subsequent fracture and excess mortality following initial fracture according to BMD. The subjects were community-dwelling participants aged 60+ years from the Dubbo Osteoporosis Epidemiology Study with incident fractures followed from 1989 to 2011...
April 2015: Journal of Bone and Mineral Research
G Jones, T Nguyen, P N Sambrook, P J Kelly, C Gilbert, J A Eisman
This longitudinal population-based study documents the incidence of all symptomatic fractures from 1989 to 1992 in an elderly, predominantly Caucasian population of males and females (> or = 60 years as at 1 January 1989) living in the geographically isolated region of the city of Dubbo, NSW, Australia. Fractures were ascertained by reviewing reports from all radiology services in the region. There were 306 fractures in 271 patients during the study period representing 11,401 person-years of observation...
September 1994: Osteoporosis International
N D Nguyen, S A Frost, J R Center, J A Eisman, T V Nguyen
UNLABELLED: We have developed clinical nomograms for predicting 5-year and 10-year fracture risks for any elderly man or woman. The nomograms used age and information concerning fracture history, fall history, and BMD T-score or body weight. INTRODUCTION: Although many fracture risk factors have been identified, the translation of these risk factors into a prognostic model that can be used in primary care setting has not been well realized. The present study sought to develop a nomogram that incorporates non-invasive risk factors to predict 5-year and 10-year absolute fracture risks for an individual man and woman...
October 2008: Osteoporosis International
2014-11-03 14:42:18
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read

Save your favorite articles in one place with a free QxMD account.


Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.